Literature DB >> 9574900

Hemolytic properties and riboflavin synthesis of Helicobacter pylori: cloning and functional characterization of the ribA gene encoding GTP-cyclohydrolase II that confers hemolytic activity to Escherichia coli.

S Bereswill1, F Fassbinder, C Völzing, A Covacci, R Haas, M Kist.   

Abstract

Various strains of Helicobacter pylori were able to lyse erythrocytes from sheep, horse, and human when grown on blood agar. The hemolysis did not depend on the production of the vacuolating cytotoxin VacA as demonstrated by the hemolytic behavior of an isogenic vacA-negative mutant strain. The hemolytic activity could be detected in cell-free supernatants and was not regulated by iron. To isolate genes coding for proteins involved in the destruction of erythrocytes, a plasmid-based DNA library was screened for expression of lytic activity on blood agar. This approach revealed that the H. pylori ribA gene confers hemolytic properties to Escherichia coli. The ribA gene encodes the enzyme GTP-cyclohydrolase II [EC 3.5.4.25] that catalyzes the initial step in the synthesis of riboflavin. The predicted amino acid sequence of the H. pylori RibA protein showed a high degree of similarity to equivalent enzymes from microorganisms and from plants. The single gene on a plasmid restored riboflavin synthesis in a ribA mutant of E. coli and induced hemolytic activity. Furthermore, ribA overexpression was associated with the production of a fluorescent yellow molecule that was not identical with riboflavin. Hemolysis was also seen for the ribA gene from E. coli, indicating that this feature was not specific for the H. pylori gene. The presence of ribA in various H. pylori strains was confirmed by Southern blot hybridization and by polymerase chain reaction with specific primers. This analysis revealed that microdiversity exists within the DNA region upstream from ribA, which was further confirmed by nucleotide sequence analysis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9574900     DOI: 10.1007/s004300050062

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  7 in total

Review 1.  MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?

Authors:  Stanislas Mondot; Pierre Boudinot; Olivier Lantz
Journal:  Immunogenetics       Date:  2016-07-08       Impact factor: 2.846

Review 2.  Genetic control of biosynthesis and transport of riboflavin and flavin nucleotides and construction of robust biotechnological producers.

Authors:  Charles A Abbas; Andriy A Sibirny
Journal:  Microbiol Mol Biol Rev       Date:  2011-06       Impact factor: 11.056

Review 3.  Metabolism and genetics of Helicobacter pylori: the genome era.

Authors:  A Marais; G L Mendz; S L Hazell; F Mégraud
Journal:  Microbiol Mol Biol Rev       Date:  1999-09       Impact factor: 11.056

4.  Evolution of new function in the GTP cyclohydrolase II proteins of Streptomyces coelicolor.

Authors:  James E Spoonamore; Annie L Dahlgran; Neil E Jacobsen; Vahe Bandarian
Journal:  Biochemistry       Date:  2006-10-03       Impact factor: 3.162

5.  Molecular analysis of riboflavin synthesis genes in Bartonella henselae and use of the ribC gene for differentiation of Bartonella species by PCR.

Authors:  S Bereswill; S Hinkelmann; M Kist; A Sander
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

6.  Riboflavin biosynthesis is associated with assimilatory ferric reduction and iron acquisition by Campylobacter jejuni.

Authors:  Rachel A Crossley; Duncan J H Gaskin; Kathryn Holmes; Francis Mulholland; Jerry M Wells; David J Kelly; Arnoud H M van Vliet; Nicholas J Walton
Journal:  Appl Environ Microbiol       Date:  2007-10-26       Impact factor: 4.792

Review 7.  Overview on the Bacterial Iron-Riboflavin Metabolic Axis.

Authors:  Ignacio Sepúlveda Cisternas; Juan C Salazar; Víctor A García-Angulo
Journal:  Front Microbiol       Date:  2018-07-05       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.